scholarly journals PDB9 LONG-TERM CLINICAL OUTCOMES OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE 2 DIABETES PROJECTED USING THE CORE DIABETES MODEL

2010 ◽  
Vol 13 (7) ◽  
pp. A284-A285 ◽  
Author(s):  
L Timlin ◽  
A Beaudet ◽  
B Wilson ◽  
D Bruhn ◽  
KS Boye ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Clinical Outcomes ◽  
The Core ◽  
Diabetes Model

Impact of Changes in HbA1c, Lipids and Blood Pressure on Long-term Outcomes in Type 2 Diabetes Patients: An Analysis Using the CORE Diabetes Model

2004 ◽  
Vol 20 (sup1) ◽  
pp. S53-S58 ◽  
Author(s):  
Andrew J. Palmer ◽  
Stéphane Roze ◽  
William J. Valentine ◽  
Michael E. Minshallb ◽  
Clarice Hayes ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Long Term Outcomes ◽  
The Core ◽  
Diabetes Model ◽  
Diabetes Patients

scholarly journals PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

2012 ◽  
Vol 15 (7) ◽  
pp. A470 ◽  
Author(s):  
V. Foos ◽  
J.L. Palmer ◽  
D. Grant ◽  
A. Lloyd ◽  
M. Lamotte ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Model

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

2016 ◽  
Vol 14 (3) ◽  
pp. 281-292 ◽  
Author(s):  
Unchalee Permsuwan ◽  
Nathorn Chaiyakunapruk ◽  
Piyameth Dilokthornsakul ◽  
Kednapa Thavorn ◽  
Surasak Saokaew
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Glargine ◽  
Neutral Protamine Hagedorn
Sign in / Sign up

Export Citation Format

Share Document